Miikka Vikkula is an expert in Genetics at de Duve Institute (Belgium). As of October 2026, ScienceLeadR ranks Miikka Vikkula in the top 1% of experts worldwide for Congenital Abnormalities, and in the top 1% of experts in Belgium for Arteriovenous Malformations. Miikka Vikkula has authored 373 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,285 (community average: 125). How the SLR is computed.

LeadR Profile

Miikka Vikkula de Duve Institute Belgium
1 285 ScienceLeadR Reputation 1285
Network Map

Genetics

Subspecialties: Cardiology - Oncology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

Université Catholique de Louvain

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 373

Citations

Citations: 25 103 1st author: 14 Last author: 154 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Zovegalisib for PIK3CA-driven vascular and lymphatic malformations: a drug evaluation.
PMID 42875408 — pharmaceutical preparations, precision medicine, therapeutics, drug evaluation
Expert Opin Investig Drugs20260
A de novo GABPA Variant in a Patient with Multifocal Cutaneous Vascular Tumors of an Unclassified Entity.
PMID 42818108 — cells, neoplasms
bioRxiv20260
Management of Venous Malformations.
PMID 42680448 — surgery, plastic, therapeutics
Clin Plast Surg20260
Volumetric perfusion fraction change in MR angiography for monitoring sclerotherapy-related changes in peripheral venous malformations.
PMID 42034595 — sclerotherapy, angiography, radiology, therapeutics
Eur J Radiol20260
Clinical Characterization of Atypical Diabetes: Insights from the GENEPEDIAB Study into the Spectrum Between Type 1 and Monogenic Diabetes.
PMID 41827917 — diabetes mellitus, cells, biomarkers, pediatrics, exome sequencing, diabetes mellitus, type 1, diabetes mellitus, type 2
Cells20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map